Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Matthew D Eldridge
Affiliation
Cancer Research UK Cambridge Institute, University of Cambridge
ORCID
Career Start Year
2010
Papers
30
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37474499
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Nat Commun
2023
37845213
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.
Nat Commun
2023
36289203
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.
Nat Commun
2022
33413557
NRG1 fusions in breast cancer.
Breast Cancer Res
2021
34291583
Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.
EMBO Mol Med
2021
32111235
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med
2020
31907488
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.
Nat Genet
2020
32747815
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung.
Nat Immunol
2020
32576827
The mutREAD method detects mutational signatures from low quantities of cancer DNA.
Nat Commun
2020
31050820
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Int J Cancer
2019
30404863
Enhanced detection of circulating tumor DNA by fragment size analysis.
Sci Transl Med
2018
30104763
Copy number signatures and mutational processes in ovarian carcinoma.
Nat Genet
2018
29899353
A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.
Nat Commun
2018
28655341
Hi-C as a tool for precise detection and characterisation of chromosomal rearrangements and copy number variation in human tumours.
Genome Biol
2017
28138154
Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Nat Genet
2017
28465312
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.
Genome Res
2017
28417298
Disseminated Mycobacterium malmoense and Salmonella Infections Associated with a Novel Variant in NFKBIA.
J Clin Immunol
2017
28974564
Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.
Genome Res
2017
28531216
Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis.
PLoS Genet
2017
26681675
Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.
Ann Oncol
2016
26572708
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.
Eur Urol
2016
27641504
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Cell
2016
27595477
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Nat Genet
2016
27594985
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.
F1000Res
2016
26159513
Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.
BMC Genomics
2015
26647970
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.
Nat Commun
2015
24600470
Multi-genome alignment for quality control and contamination screening of next-generation sequencing data.
Front Genet
2014
24952744
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Nat Genet
2014
22057237
Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.
Nat Genet
2011
20080953
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.
Genes Dev
2010
1 - 30 of 30
Column Actions
Search
Recommended Authors
Job van Riet
Erasmus MC Cancer Institute
Career Start Year
2017
Number of shared co-authors
4
Andrew M K Brown
Ontario Institute for Cancer Research
Career Start Year
2012
Number of shared co-authors
20
Richard de Borja
The Hospital for Sick Children
Career Start Year
2012
Number of shared co-authors
23
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2011
Number of shared co-authors
20
Chandra Sekhar Pedamallu
Broad Institute
Career Start Year
2009
Number of shared co-authors
7
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
5
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
1
Maria A Doyle
Peter MacCallum Cancer Centre
Career Start Year
2007
Number of shared co-authors
4
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year
2007
Number of shared co-authors
4
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year
2006
Number of shared co-authors
7
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
14
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
3
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
14
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Career Start Year
2004
Number of shared co-authors
9
Peter Van Loo
The Francis Crick Institute
Career Start Year
2003
Number of shared co-authors
40
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
7
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
7
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
11
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
4
Malachi Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
11
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
26
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2001
Number of shared co-authors
9
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
26
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
0
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Career Start Year
1999
Number of shared co-authors
40
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
14
Marco A Marra
University of British Columbia
Career Start Year
1993
Number of shared co-authors
40
Elaine R Mardis
The Ohio State University
Career Start Year
1988
Number of shared co-authors
17
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
23
row(s) 1 - 30 of 30
Collaborators
Lawrence Bower
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
9
Andy G Lynch
University of St Andrews
Co-authored papers
8
Simon Tavar??
Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers
7
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
6
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
6
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers
5
Iain A McNeish
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers
5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
4
Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
4
Darren Ennis
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers
4
Charlie E Massie
University of Cambridge
Co-authored papers
4
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
3
Nicholas Brian Shannon
Singapore General Hospital
Co-authored papers
3
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
3
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers
3
Charlotte L Anderson
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
2
Jason S Carroll
Co-authored papers
2
Liz-Anne Lewsley
CRUK Clinical Trials Unit, University of Glasgow
Co-authored papers
2
Samuel Aparicio
University of British Columbia
Co-authored papers
2
Dilrini De Silva
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
2
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers
2
Oscar M Rueda
University of Cambridge
Co-authored papers
2
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers
2
José Baselga
Co-authored papers
1
David Jones
Wellcome Sanger Institute
Co-authored papers
1
Rafael Vald??s-Mas
Weizmann Institute of Science
Co-authored papers
1
Jonathan Hinton
Inivata Ltd
Co-authored papers
1
Sean M Grimmond
The University of Melbourne
Co-authored papers
1
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers
1
Sigve Nakken
University of Oslo
Co-authored papers
1
1 - 30